{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:03:55Z","timestamp":1784347435259,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.msard.2025.106815","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T04:07:47Z","timestamp":1761365267000},"page":"106815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Management of neuropathic pain and paresthesia in patients with multiple sclerosis: A systematic review and network meta-analysis"],"prefix":"10.1016","volume":"104","author":[{"given":"Marzieh","family":"Mohamadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoob","family":"Molla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Orakifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Bahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab Morshedi","family":"Yekta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha","family":"Bervis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Hesampour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106815_bib0001","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clineuro.2016.08.015","article-title":"Evaluation of pulsing magnetic field effects on paresthesia in multiple sclerosis patients, a randomized, double-blind, parallel-group clinical trial","volume":"149","author":"Afshari","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.msard.2025.106815_bib0002","article-title":"Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews","author":"Amatya","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.msard.2025.106815_bib0003","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1468-1331.2004.00815.x","article-title":"Pain and sensory complaints in multiple sclerosis","volume":"11","author":"Beiske","year":"2004","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2025.106815_bib0004","series-title":"Non-motor Symptoms in Multiple Sclerosis","author":"Beiske","year":"2009"},{"key":"10.1016\/j.msard.2025.106815_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnhum.2019.00031","article-title":"The effects of transcutaneous spinal direct current stimulation on neuropathic pain in multiple sclerosis: clinical and neurophysiological assessment","volume":"13","author":"Berra","year":"2019","journal-title":"Front. Hum. Neurosci."},{"issue":"9","key":"10.1016\/j.msard.2025.106815_bib0006","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.clinthera.2007.09.023","article-title":"A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis","volume":"29","author":"Breuer","year":"2007","journal-title":"Clin. Ther."},{"issue":"7","key":"10.1016\/j.msard.2025.106815_bib0007","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jmpt.2018.12.010","article-title":"Effects of nonpharmaceutical treatments on symptom management in adults with mild or moderate multiple sclerosis: a meta-analysis","volume":"42","author":"Byrnes","year":"2019","journal-title":"J. Manipulat. Physiol. Ther."},{"issue":"18","key":"10.1016\/j.msard.2025.106815_bib0008","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1080\/14656566.2020.1757649","article-title":"An update on the pharmacological management of pain in patients with multiple sclerosis","volume":"21","author":"Chisari","year":"2020","journal-title":"Expert. Opin. PharmacOther"},{"issue":"4","key":"10.1016\/j.msard.2025.106815_bib0009","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/AJP.0b013e318190862b","article-title":"Sensory complaints of the upper extremities in multiple sclerosis: relative efficacy of nortriptyline and transcutaneous electrical nerve stimulation","volume":"25","author":"Chitsaz","year":"2009","journal-title":"Clin. J. Pain."},{"issue":"5","key":"10.1016\/j.msard.2025.106815_bib0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/1352458506071346","article-title":"The scope and nature of pain in persons with multiple sclerosis","volume":"12","author":"Ehde","year":"2006","journal-title":"Mult. Scler. J."},{"issue":"6","key":"10.1016\/j.msard.2025.106815_bib0011","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/j.1532-2149.2011.00073.x","article-title":"A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis","volume":"16","author":"Falah","year":"2012","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.msard.2025.106815_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103925","article-title":"Efficacy of Fluoxetine, Riluzole and Amiloride in treating neuropathic pain associated with secondary progressive multiple sclerosis. Pre-specified analysis of the MS-SMART double-blind randomised placebo-controlled trial","volume":"63","author":"Foley","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.msard.2025.106815_bib0013","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jpain.2007.03.005","article-title":"Chronic pain in multiple sclerosis: prevalence, characteristics, and impact on quality of life in an Australian community cohort","volume":"8","author":"Khan","year":"2007","journal-title":"J. Pain."},{"key":"10.1016\/j.msard.2025.106815_bib0014","article-title":"The effect of Transcutaneous Electrical Nerve Stimulation (TENS) and interferential Currents (IFC) on pain, functional capacity, and quality of life in patients with multiple sclerosis: a randomized controlled, single-blinded study","volume":"71","author":"Kirmaci","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106815_bib0015","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s00415-012-6739-4","article-title":"A double-blind, randomized, placebo-controlled, parallel-group study of THC\/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis","volume":"260","author":"Langford","year":"2013","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2025.106815_bib0016","first-page":"189","article-title":"Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis","volume":"34","author":"Palm","year":"2016","journal-title":"Restor. Neurol. Neurosci."},{"issue":"5","key":"10.1016\/j.msard.2025.106815_bib0017","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1249\/MSS.0000000000000834","article-title":"Exercising impacts on fatigue, depression, and paresthesia in female patients with multiple sclerosis","volume":"48","author":"Razazian","year":"2016","journal-title":"Med. Sci. Sports Exercise"},{"issue":"6","key":"10.1016\/j.msard.2025.106815_bib0018","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","article-title":"Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis","volume":"65","author":"Rog","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2025.106815_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104029","article-title":"Effects of acceptance and commitment therapy (ACT) and mindfulness-based stress reduction (MBSR) on symptoms and emotional competencies in individuals with multiple sclerosis","volume":"67","author":"Sadeghi-Bahmani","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106815_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.07.032","article-title":"Compared to an active control condition, in persons with multiple sclerosis two different types of exercise training improved sleep and depression, but not fatigue, paresthesia, and intolerance of uncertainty","volume":"36","author":"Sadeghi-Bahmani","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5\u20136","key":"10.1016\/j.msard.2025.106815_bib0021","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000481089","article-title":"Dronabinol is a safe long-term treatment option for neuropathic pain patients","volume":"78","author":"Schimrigk","year":"2017","journal-title":"Eur. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106815_bib0022","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1191\/1352458503ms925oa","article-title":"Refiexology treatment relieves symptoms of multiple sclerosis: a randomized controlled study","volume":"9","author":"Siev-Ner","year":"2003","journal-title":"Mult. Scler. J."},{"issue":"5","key":"10.1016\/j.msard.2025.106815_bib0023","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/01.WNL.0000137047.85868.D6","article-title":"The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study","volume":"63","author":"Solaro","year":"2004","journal-title":"Neurology."},{"issue":"7460","key":"10.1016\/j.msard.2025.106815_bib0024","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","article-title":"Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial","volume":"329","author":"Svendsen","year":"2004","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.msard.2025.106815_bib0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pain.2005.01.015","article-title":"Sensory function and quality of life in patients with multiple sclerosis and pain","volume":"114","author":"Svendsen","year":"2005","journal-title":"Pain."},{"key":"10.1016\/j.msard.2025.106815_bib0026","author":"Trisolini","year":"2010","journal-title":"Global Economic Impact of Multiple Sclerosis"},{"issue":"8","key":"10.1016\/j.msard.2025.106815_bib0027","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/papr.12127","article-title":"A randomized, double-blind, placebo-controlled trial of duloxetine for the treatment of pain in patients with multiple sclerosis","volume":"14","author":"Vollmer","year":"2014","journal-title":"Pain Pract."},{"issue":"12","key":"10.1016\/j.msard.2025.106815_bib0028","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1093\/pm\/pnaa128","article-title":"The effect of transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis: randomized controlled trial","volume":"21","author":"Young","year":"2020","journal-title":"Pain Med."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:37:54Z","timestamp":1784345874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825005577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"alternative-id":["S2211034825005577"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106815","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of neuropathic pain and paresthesia in patients with multiple sclerosis: A systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106815"}}